Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 458
Immune Disorders Drugs 196
Cardiovascular Drugs 161
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 113
Clinical Trials 107
Central Nervous System Drugs 106
Musculoskeletal Disorders Drugs 98
Pharmaceuticals 96
Leukemia Drugs 82
Hematological Drugs 80
Liver and Kidney Disorders Drugs 76
Lymphoma Drugs 62
Dermatological Drugs 59
Diabetes Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Drug Delivery 36
Pharmaceutical Intermediates 34
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
Prostate Cancer Drugs 18
HIV/AIDS Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Vaccines 8
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

2,424 Results (Page 71 of 122)
- Relevance
  Sort by

Anti-Inflammatory Drugs - Global Strategic Business Report

 Report
August 2025
488 Pages
Global

From

€5205EUR$5,850USD£4,494GBP

Immunotoxins - Global Strategic Business Report

 Report
August 2025
377 Pages
Global

From

€5205EUR$5,850USD£4,494GBP

Genitourinary Drugs Market Report and Forecast 2024-2032

 Report
May 2024
140 Pages
Global

From

€4403EUR$4,949USD£3,802GBP

Indolent Lymphoma Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
September 2024
86 Pages
Global

From

€3500EUR$4,214USD£3,128GBP

Breast Cancer Monoclonal Antibodies Market 2024-2028

 Report
July 2024
182 Pages
Global

From

€2224EUR$2,500USD£1,921GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Graft Versus Host Disease Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
112 Pages
Global

From

€3500EUR$4,214USD£3,128GBP

Hodgkin Lymphoma Treatment Market - Growth, Trends and Forecasts (2023 - 2028)

 Report
April 2023
110 Pages
Global

From

€4226EUR$4,750USD£3,649GBP

Blood Preparation Market Size, Share & Trends Analysis Report By Product (Whole Blood, Blood Components, Blood Derivatives), Antithrombotic And Anticoagulants Type, By Application, By Region, And Segment Forecasts, 2023 - 2030

 Report
September 2023
180 Pages
Global

From

€5294EUR$5,950USD£4,571GBP

Vitiligo Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3995EUR$4,490USD£3,449GBP

Malignant Lymphoma Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2024
74 Pages
Global

From

€3500EUR$4,214USD£3,128GBP

Cutaneous T-Cell Lymphoma Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
114 Pages
Global

From

€4226EUR$4,750USD£3,649GBP

Peptide Therapeutics Market 2024-2028

 Report
June 2024
148 Pages
Global

From

€2224EUR$2,500USD£1,921GBP

Protein Therapeutics Market 2024-2028

 Report
May 2024
191 Pages
Global

From

€2224EUR$2,500USD£1,921GBP

Metabolic Disorder Therapeutics - Global Strategic Business Report

 Report
August 2025
286 Pages
Global

From

€5205EUR$5,850USD£4,494GBP

Pulmonary Embolism Therapeutics Market 2025-2029

 Report
June 2025
206 Pages
Global

From

€2224EUR$2,500USD£1,921GBP

Global CD19 Antibody Market & Clinical Pipeline Outlook 2028

 Report
October 2023
420 Pages
Global

From

€2322EUR$2,610USD£2,005GBP

€2580EUR$2,900USD£2,228GBP

Germany OTC Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

 Report
July 2024
80 Pages
Germany

From

€4226EUR$4,750USD£3,649GBP

Immunomodulator Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2023
102 Pages
Global

From

€3500EUR$4,214USD£3,128GBP

Therapeutic Antibody Market (2023 Edition): Analysis By Antibody Type (Monoclonal, Bispecific, Drug Conjugates, Others), Source (Fully human, Humanized, Others), By Application, By Region, By Country: Market Insights and Forecast (2019-2029)

 Report
February 2024
260 Pages
Global

From

€2180EUR$2,450USD£1,882GBP

Pancreatic Cancer - Market Insight, Epidemiology And Market Forecast - 2032

 Report
August 2022
285 Pages
Global

From

€8452EUR$9,500USD£7,298GBP

2,424 Results (Page 71 of 122)
- 1
- 69
- 70
- 71
- 72
- 73

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.